Celemics Inc
Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea. The company offers whole exome sequencing panels; NGS target enrichment panels; customized and ready-to-use enrichment panels; and modular accessories, including library preparation kits, double standard Cdna synthesis, hybridization enhancer, celan-up and streptavidin beads, CeleNM beads, and polymerase. It als… Read more
Celemics Inc (331920) - Total Liabilities
Latest total liabilities as of September 2025: ₩1.94 Billion KRW
Based on the latest financial reports, Celemics Inc (331920) has total liabilities worth ₩1.94 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Celemics Inc - Total Liabilities Trend (2017–2024)
This chart illustrates how Celemics Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Celemics Inc Competitors by Total Liabilities
The table below lists competitors of Celemics Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
IMT Co., Ltd.
KQ:451220
|
Korea | ₩31.19 Billion |
|
US Global Investors Inc
NASDAQ:GROW
|
USA | $3.05 Million |
|
Mieco Chipboard Bhd
KLSE:5001
|
Malaysia | RM300.16 Million |
|
Silvano Fashion Group AS
WAR:SFG
|
Poland | zł12.73 Million |
|
Ballarpur Industries Limited
NSE:BALLARPUR
|
India | ₹8.96 Billion |
|
Silkeborg IF Invest A/S
CO:SIF
|
Denmark | Dkr404.00 Million |
|
Kinatico Ltd
AU:KYP
|
Australia | AU$6.19 Million |
|
Garanti Faktoring AS
IS:GARFA
|
Turkey | TL21.69 Billion |
Liability Composition Analysis (2017–2024)
This chart breaks down Celemics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.19 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.07 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Celemics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Celemics Inc (2017–2024)
The table below shows the annual total liabilities of Celemics Inc from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩2.23 Billion | -0.29% |
| 2023-12-31 | ₩2.24 Billion | -38.26% |
| 2022-12-31 | ₩3.62 Billion | +3.15% |
| 2021-12-31 | ₩3.51 Billion | +182.79% |
| 2020-12-31 | ₩1.24 Billion | -39.20% |
| 2019-12-31 | ₩2.04 Billion | -94.76% |
| 2018-12-31 | ₩38.97 Billion | +141.25% |
| 2017-12-31 | ₩16.15 Billion | -- |